Abstract
Fragment Based Drug Discovery (FBDD) continues to advance as an efficient and alternative screening paradigm for the identification and optimization of novel chemical matter. To enable FBDD across a wide range of pharmaceutical targets, a fragment screening library is required to be chemically diverse and synthetically expandable to enable critical decision making for chemical follow-up and assessing new target druggability. In this manuscript, the Pfizer fragment library design strategy which utilized multiple and orthogonal metrics to incorporate structure, pharmacophore and pharmacological space diversity is described. Appropriate measures of molecular complexity were also employed to maximize the probability of detection of fragment hits using a variety of biophysical and biochemical screening methods. In addition, structural integrity, purity, solubility, fragment and analog availability as well as cost were important considerations in the selection process. Preliminary analysis of primary screening results for 13 targets using NMR Saturation Transfer Difference (STD) indicates the identification of uM–mM hits and the uniqueness of hits at weak binding affinities for these targets.
This is a preview of subscription content, access via your institution.








References
Congreve M, Chessari G, Tisi D, Woodhead A (2008) J Med Chem 51:3661
Albert J, Blomberg N, Breeze A, Brown A, Burrows J, Edwards P, Folmer R, Geschwindner S, Griffen E, Kenny P, Nowak T, Olsson L, Sanganee H, Shapiro A (2007) Curr Topics Med Chem 7:1600
Shuker S, Hajduk P, Meadows R, Fesik S (1996) Science 274:1531
Lepre C, Peng J, Fejzo J, Abdul-Manan N, Pocas J, Jacobs M, Xie X, Moore J (2002) Comb Chem High Throughput Screen 5:583
Lipinski C, Lombardo F, Dominy B, Feeney P (2001) Adv Drug Deliv Rev 46:3
Carr R, Congreve M, Murray C, Rees D (2005) Drug Discov Today 10:987
Hopkins A, Groom C, Alex A (2004) Drug Discov Today 9:430
Howard N, Abell C, Blakemore W, Chessari G, Congreve M, Howard S, Jhoti H, Murray C, Searvers L, van Montfort R (2006) J Med Chem 49:1346
Saxty G, Woodhead S, Berdini V, Davies T, Verdonk M, Wyatt P, Boyle R, Barford D, Downham R, Garrett M, Carr R (2007) J Med Chem 50:2293
Hajduk P, Huth J, Tse C (2005) Drug Discov Today 10:1675
Baurin N, Aboul-Ela F, Barril X, Davis B, Drysdale M, Dymock B, Finch H, Fromont C, Richardson C, Simmonite H, Hubbard RE (2004) J Chem Inf Comp Sci 44:2157
Blomberg N, Cosgrove DA, Kenny PW, Kolmodin K (2009) J Comput Aided Mol Des 23:513
Schuffenhauer A, Ruedisser S, Marzinzik AL, Jahnke W, Blommers M, Selzer P, Jacoby E (2005) Curr Topics Med Chem 5:751
Leach A, Hann M, Burrows J, Griffen E (2006) Structure-based drug discovery. Royal Society of Chemistry, Cambridge
Lepre C (2001) DDT 6:133
Erlanson D, McDowell R, O’Brien T (2004) J Med Chem 47:3463
Fattori D, Squarcia A, Bartoli S (2008) Drugs R D 9:217
Barker J, Courtney S, Hesterkamp T, Ullmann D, Whittaker M (2006) Expert Opin Drug Discov 1:225
Mayer M, Meyer B (1999) Angew Chem Int Ed 38:1784
Dalvit C, Fogliatto G, Stewart A, Veronest M, Stockman B (2001) J Biomol NMR 21:349
Wang Y, Liu D, Wyss D (2004) Magn Reson Chem 42:485
Hartshorn M, Murray C, Cleasby A, Frederickson M, Tickle I, Jhoti H (2005) J Med Chem 48:403
Hubbard R, Davies B, Chen I, Drysdale M (2007) Curr Topics Med Chem 7:1568
Neumann T, Junker H, Schmidt K, Sekul R (2007) Curr Topics Med Chem (Sharjah, United Arab Emirates) 7:1630
Hubbard R, Chen I, Davies B (2007) Curr Opin Drug Discov Dev 10:289
Card G, Blasdel L, England B, Zhang C, Suzuki Y, Gillette S, Fong D, Ibrahim P, Artis D, Bollag G, Milburn M, Kim S, Schlessinger J, Zhang K (2005) Nat Biotechnol 23:201
Jhoti H, Cleasby A, Verdonk M, Williams G (2007) Curr Opin Chem Biol 11:485
Hann M, Leach A, Harper G (2001) J Chem Inf Comp Sci 41:856
Schuffenhauer A, Floersheim P, Acklin P, Jacoby E (2003) J Chem Inf Comp Sci 43:391
Hu Q, Peng Z, Kostrowicki J, Kuki A (2010) In: Zhou Z, Walter J (eds) Chemical library design in methods in molecular biology (MiMB) series. Humana Press, New York, pp 253–276
Congreve M, Carr R, Murray C, Jhoti H (2003) Drug Discov Today 8:876
Ladbury J, Klebe G, Freire E (2010) Nat Rev Drug Discov 9:23
Burrows J (2004) Soc Med Res Trends Drug Discov
WOMBAT (2005) Santa Fe available at: http://www.sunsetmolecular.com/
Oprea T, Blaney J (2006) In: Jahnke W, Erlanson DA (eds) Fragment-based approaches in drug discovery, pp 91–111
Njardarson Group, Kwon L, Rogers E, McGrath N, Brichacek M, Njarðarson J (2006) Available at: http://cbc.arizona.edu/njardarson/group/homepage
Teague SJ, Davis AM, Leeson PD, Oprea TI (1999) Angew Chem Int Ed 38:3743
Allu T, Oprea T (2005) J Chem Inf Model 45:1237
Reynolds C, Tounge B, Bembenek S (2008) J Med Chem 51:2432
Irwin J, Shoichet B (2005) J Chem Inf Model 45:177
Zhou J, Shi S, Na J, Peng Z, Thacher T (2009) J Comput Aided Mol Des 23:725
Ertl P, Rohde B, Selzer P (2000) J Med Chem 43:3714
Gao SVH, Lee P (2002) Pharm Res 19:497
Leadscope, Inc., 1393 Dublin Road, Columbus, OH 43215
Roberts G, Myatt G, Johnson W, Cross K, Blower P (2000) J Chem Inf Comput Sci 40:1302
Daylight Chemical Information Systems Inc In: Aliso Viejo, CA 92656, USA
Ward J (1963) J Am Stat Assoc 58:236
PipelinePilot In: 10188 Telesis Court, Suite 100, San Diego, CA 92121-4779
Durant J, Leland B, Henry D, Nourse J (2002) J Chem Inf Comput Sci 42:1273
Bemis G, Murcko M (1996) J Med Chem 39:2887
Corina Inc In: molecular-networks GmbH
Murral N, Davies E (1990) J Chem Inf Comp Sci 30:312
Mills J, Dean P (1996) J Comput Aided Mol Des 10:607
Bakken G, Du J, Li D, Lu J, Schulte G, Sridaharan S, Tinniswood A, Miller M (2006)
Paolini G, Shapland R, van Hoorn W, Mason J, Hopkins A (2006) Nat Biotechnol 24:805
Gasteiger J, Rudolph C, Sadowski J (2004) Tetrahedron Comput Methodol 3:537
ROCS OpenEye Scientific Software In: Santa Fe, New Mexico, USA
Jakes S, Willet P (1986) J. Mol. Graphics 4:12
Davies K, Briant C (1995) In: MGMS meeting, Leeds
Stockman B, Lodovice I, Fisher D, McColl A, Xie Z (2007) J Biomol Screen 12:457
Hu Q, Yan J, Withka J, Sahasrabudhe P, Moore C, Na J, Narasimhan L (2009) Abstracts of papers, 238th ACS National Meeting, Washington, DC, USA
Chen I, Hubbard R (2009) J Comput Aided Mol Des 23:603
Acknowledgments
Tudor Oprea for the SMCM program; Marty Marx, Kim Daoust, James Forman and Bob Mecca for RI support; Parag Sahasrabudhe, Hong Wang, Diana Omechinsky, Kris Borzilleri, Cathy Moore and Jiangli Yan for NMR support; Gaia Paolini and Zhengwei Peng for computational input; Bob Chambers, Kim Matus, Kyle Blair, Lisa Thomasco, Jan Snape, Shirell Gray, Jola Nowakowski, Maria Anhalt, Steve Curioso, Craig Hines, Diane Johnson, Bernadette Udasco, Jason Harraden, Erin Cyr, Betsy Poe, Monica Gorny, Elizabeth Mostowy, Holly McKeith, Jed Morris, Tim Britt, Frank Girardi, C.K. Chan for library preparation and sample logistics support; G. Tim Benson, Mike Clark, Tony Wood, Ron Wester and Suvit Thaisrivongs and Alan Mathiowetz for initiative support.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lau, W.F., Withka, J.M., Hepworth, D. et al. Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics. J Comput Aided Mol Des 25, 621–636 (2011). https://doi.org/10.1007/s10822-011-9434-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-011-9434-0
Keywords
- Fragment screening
- Fragment based drug design
- Library design
- Chemical diversity
- Chemical space